Principal Scientist, Health Economics and Decision Sciences

Job Description

We are a research-driven biopharmaceutical company. Our mission is built on the simple premise that if we “follow the science” that great medicines can make a significant impact to our world. We believe that a research driven
enterprise dedicated to world-class science can succeed by inventing medicine and vaccine innovations that make a difference for patients across the globe.

In BARDS (Biostatistics and Research Decision Sciences), a distinguished department within our company’s renowned Research and Development division, quantitative scientists, in partnership with other subject matter experts, apply state-of-the art scientific methodologies and tools to enable the discovery, development, regulatory approval, manufacturing, and marketing of medical drugs and vaccines for the benefit of patients and global human health.

We have an exciting, new opportunity for an Principal Scientist, Health Economics & Decision Sciences (HEDS) to join our team. The preferred location is Rahway, NJ; alternative locations in USA (Boston, MA, West Point, PA, or Philadelphia, PA) and UK (London) are possible. HEDS is part of our company's Biostatistics and Research Decision Sciences group, and works in collaboration with internal and external partners (such as the Center for Observational and Real-World Evidence, CORE) to generate the evidence to support scientific and commercial value of our company's portfolio to optimize access, reimbursement, and patient outcomes. Our group provides strategic and technical leadership to enable patient access, measure and quantify the value of our products, inform internal and external decisions, and shape methodology and external health policy and practice. This position will focus on oncology products.

Under the direction of a HEDS Senior Director, the Principal Scientist provides strategic development and use of industry-leading predictive and economic models to enhance our understanding of disease and to quantify and communicate the value of our oncology products to patients, providers, and payers.

• Serve as the HEDS lead for one or more value evidence teams to develop health economic, disease, and predictive models to enable business insights for the product.

• Utilize discovery, real world evidence, clinical trial and published data, and publicly available information and tools to provide economic and integrated models to answer key questions in all phases of drug and vaccine development – Phase I through loss of data exclusivity.

• Advance the use of integrated quantitative approaches, focusing on economic, disease, and predictive modeling and simulation in partnership with other internal groups and external organizations.

• Development and maintenance of health quality global health economic models and tools in-house or in collaboration with external vendors to provide critical business insights and fully demonstrate the value of our company’s products.

• Support and training of HEDS models and tools to support country/regional team adaptations and communications with external stakeholders.

• Dissemination of health economic data via presentations at congresses and publications in scientific journals.

• Work closely with external collaborators (clinical/economic thought leaders, payer/HTA experts, alliance partners) and internal teams to ensure that new methodologies, models and advanced analytics are fully utilized for our products.

• Maintain awareness of external data, modeling methodologies and IT tools to collaborate across relevant internal stakeholders to enhance our company's capabilities in health economic modeling, simulation, and data visualization.

• Partner in defining and implementing the HEDS vision and strategy to develop an innovative, world class Center of Excellence.

• Ensure sharing of work product and relevant best practices across the company's enterprise.

Education

• PhD (preferred) or Masters degree, in Health Economics, Biostatistics, Health Services Research, Actuarial Sciences or a closely related, quantitative field

Required Experience and Skills:

• Relevant experience in health economics and outcomes research (HEOR) of 5 or more years beyond PhD (or 7 or more years beyond Masters degree)

• Highly experienced in the economic evaluation of oncology drugs and interventions

• Strong expertise in the conceptualization, design, development and dissemination of health economic model approaches to enable internal and external decisions

• Leadership skills, with experience in managing resources and driving implementation

• Track record of submissions to Health Technology Assessment bodies and research publications in conferences and pee